Andrew Wilber
- Oncology top 5%
- Lymphatic System and Diseases 6
- Cancer Cells and Metastasis 6
- CAR-T cell therapy research 5
- Genetics top 5%
- Virus-based gene therapy research 16
- Animal Genetics and Reproduction 9
- Hemoglobinopathies and Related Disorders 6
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 14
- CRISPR and Genetic Engineering 8
- Cancer Research top 5%
- Genetics top 5%
- Virus-based gene therapy research 16
- Animal Genetics and Reproduction 9
- Hemoglobinopathies and Related Disorders 6
- Co-authors
- R. Scott McIvorDerek A. PersonsArthur W. NienhuisDavid A. LargaespadaPerry B. HackettChristopher B. ChambersAya KobayashiKounosuke Watabe
- Cited by
- OncologyGeneticsMolecular Biology
- Journals
- The Journal of Experimental Medicine (2 papers)SHILAP Revista de lepidopterología (1 paper)The Journal of Cell Biology (1 paper)
- Partner nations
- United StatesJapanChina
In The Last Decade
Andrew Wilber
62 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 113
- Oncology 895
- Genetics 308
- Molecular Biology 1.7k
- Cancer Research 353
- Genetics 556
Countries citing papers authored by Andrew Wilber
This map shows the geographic impact of Andrew Wilber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Wilber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Wilber more than expected).
Fields of papers citing papers by Andrew Wilber
This network shows the impact of papers produced by Andrew Wilber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Wilber. The network helps show where Andrew Wilber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Wilber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2022 | 23 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 16 | |
| 6 | 2018 | 46 | |
| 7 | 2016 | 21 | |
| 8 | 2016 | 5 | |
| 9 | 2015 | 28 | |
| 10 | 2015 | 5 | |
| 11 | 2013 | 146 | |
| 12 | 2012 | 30 | |
| 13 | 2012 | 11 | |
| 14 | 2011 | 160 | |
| 15 | 2011 | 25 | |
| 16 | 2009 | 29 | |
| 17 | 2009 | 19 | |
| 18 | 2008 | 47 | |
| 19 | 2006 | 260 | |
| 20 | 2005 | 53 |
About Andrew Wilber
Andrew Wilber is a scholar working on Genetics, Oncology and Genetics, having authored 62 papers that have together received 2.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), RNA Interference and Gene Delivery (14 papers), Animal Genetics and Reproduction (9 papers), CRISPR and Genetic Engineering (8 papers), Lymphatic System and Diseases (6 papers), Cancer Cells and Metastasis (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (895 citations), Genetics (308 citations) and Molecular Biology (1.7k citations). Andrew Wilber has collaborated with scholars based in United States, Japan and China. Frequent co-authors include R. Scott McIvor, Derek A. Persons, Arthur W. Nienhuis, David A. Largaespada, Perry B. Hackett, Christopher B. Chambers, Aya Kobayashi, Kounosuke Watabe, Puspa R. Pandey and Misako Watabe. Their work appears in journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.